The AI Landscape in Life Sciences
Module 1 · Foundations: AI in the Life-Science Lifecycle

The AI Landscape in Life Sciences

Distinguish the three kinds of AI you'll meet in life-science work, see where each shows up across the product lifecycle, and learn the four fluency competencies this course builds.

One Word, Three Very Different Things

“We’re using AI” can mean almost anything in a life-science company. A protein-structure model, a chatbot that drafts a clinical study report section, and a vision system inspecting vials on a fill line are all “AI,” but they fail differently, are regulated differently, and need different kinds of checking.

Before you decide how much to trust any tool, sort it into one of three groups.

1. Scientific and predictive models

Purpose-built models trained on scientific data to make a specific prediction:

  • Structure prediction (for example, AlphaFold and its successors) estimates how a protein folds or how molecules bind.
  • Property prediction scores candidate molecules for solubility, toxicity, or binding affinity.
  • Image analysis counts cells, segments tissue, or flags anomalies in histology slides.
  • Operational prediction forecasts trial enrollment, equipment failure, or batch yield.

These models usually output a number, a structure, or a classification, often with a confidence score. Their main risk is being used outside the conditions they were trained and validated on.

2. General-purpose generative assistants

Large language models (LLMs) such as Claude, ChatGPT, Gemini, or Copilot, used to read, summarize, draft, translate, or write code. They’re flexible and fluent, which is exactly the problem: they produce confident text whether or not it’s true. Most of this course focuses here, because these are the tools most professionals now use daily, often without any formal process.

3. AI embedded in regulated systems

AI features built into validated systems: a quality-management system that suggests deviation root causes, a pharmacovigilance platform that auto-codes adverse events, an electronic data capture system that flags data anomalies, or a visual-inspection system on a manufacturing line. These sit inside GxP processes (Good Laboratory, Clinical, Manufacturing, and Pharmacovigilance Practice), so they carry validation, data-integrity, and audit-trail obligations that a stand-alone chatbot does not.

Scientific andpredictive modelsEXAMPLESStructure, property,image predictionMAIN RISKUsed outside itstraining domainMAIN CONTROLCheck applicabilitydomain and confidenceGenerativeassistantsEXAMPLESChatbots, writing andcoding assistantsMAIN RISKConfident text thatisn’t trueMAIN CONTROLVerify againstprimary sourcesAI embedded inGxP systemsEXAMPLESAI features in QMS,PV, EDC, inspectionMAIN RISKUnvalidated changeto a GxP processMAIN CONTROLValidation andchange controlRegulatory obligations increase
⚠️ Common Pitfall: Assuming the Vendor Validated It for You

Common mistake: “It’s a validated system, so the new AI feature is validated too.”

A vendor’s release notes are not your validation. When AI is added to a GxP system, your organization still has to assess the feature against your intended use, document that assessment, and control changes to it. Ask your quality unit before turning on any new AI feature in a validated system.


Where AI Shows Up Across the Lifecycle

  1. 1 Discovery

    Targets, molecules, literature

  2. 2 Preclinical

    Image analysis, tox prediction

  3. 3 Clinical

    Protocols, recruitment, data review

  4. 4 Regulatory

    Submissions, labeling, queries

  5. 5 Manufacturing

    Inspection, process control

  6. 6 Post-market

    Safety, medical information

The further right you move, the closer AI output gets to a patient and the heavier the regulatory obligations become. A wrong literature summary in discovery wastes time. A wrong adverse-event assessment in post-market safety can delay a safety signal.


The Four Competencies

This course is organized around the 4D AI Fluency Framework:

Delegation what to hand to AI Description how to ask well Discernment how to check output Diligence how to stay accountable
  • Delegation: deciding which tasks AI should do, which it should assist with, and which it should stay out of, given the scientific, patient, and regulatory stakes.
  • Description: giving AI the context, constraints, and format it needs, without giving it data it shouldn’t have.
  • Discernment: checking AI output against primary sources, raw data, and your own expertise.
  • Diligence: owning the result. Documenting AI use where it matters, following SOPs, and being transparent with colleagues, regulators, journals, and patients.

The four competencies form a loop. What you learn while checking output (Discernment) changes what you delegate next time.


How This Course Is Organized

ModuleFocus
1. FoundationsThe AI landscape and how AI fails in science
2. Delegation and data protectionRisk-tiered delegation; confidential, patient, and proprietary data
3. Research and discoveryLiterature, writing, data analysis, and discovery models
4. Clinical developmentTrial documents, operations, and pharmacovigilance
5. Regulatory and qualityGxP, data integrity, validation, and the regulatory landscape
6. Communication and accountabilityMedical affairs, commercial content, and your 90-day plan

You don’t need to work in every function. Each module stands on its own after Modules 1 and 2, so skip ahead to the parts of the lifecycle you touch.

🧪 Try It: Inventory Your AI Use

List every AI tool you used, or that touched your work, in the last two weeks. For each one, note:

  1. Which of the three groups it falls in (scientific model, generative assistant, embedded in a regulated system).
  2. Whether it’s an approved tool at your organization, and how you know.
  3. Whether its output fed into anything GxP, anything submitted externally, or anything a patient will see.

Keep this list. You’ll use it again in Module 2 and in your 90-day plan.

🧠 Knowledge Check

1. A vendor adds an AI root-cause suggestion feature to your validated quality-management system. What's the right first step?

2. What is the main risk of scientific and predictive models such as structure or property predictors?

3. Which competency covers documenting AI use and being transparent with regulators and journals?

Up Next

Before deciding what to delegate, you need to know how AI goes wrong in scientific work. The next lesson covers the failure modes that matter most.